Repligen | RGEN - مصروفات التشغيل





مصروفات التشغيل تغيير تاريخ
Agilent USD 1.44B 27M 2025-12
Align Technology USD 862.03M 39.18M 2026-03
Bio Techne USD 235.92M 5.5M 2026-03
BioMarin Pharmaceutical USD 636.56M 39.61M 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Bruker USD 813.2M 87.7M 2026-03
Charles River Laboratories USD 875.93M 42.48M 2026-03
Danaher USD 52.95B 47.61B 2026-03
Dentsply International USD 1.32B 895M 2026-03
General Electric Aerospace USD 18.06B 7.11B 2026-03
Henry Schein USD 3.17B 77M 2026-03
Illumina USD 852M 51M 2026-03
IQVIA Holdings USD 6.22B 4.53B 2026-03
Mettler Toledo International USD 713.2M 64.61M 2026-03
Myriad Genetics USD 212.8M 16.2M 2025-12
OraSure Technologies USD 40.35M 2.45M 2025-12
Pacific Biosciences Of California USD 97.83M 41.29M 2025-12
Pfizer USD 90.1B 77.19B 2026-03
Repligen USD 174.27M 3.67M 2026-03
Revvity USD 628.34M 2.12M 2026-03
Standard Biotools USD 45.72M 2.7M 2025-12
Thermo Fisher Scientific USD 9.09B 821M 2026-03
Waters USD 1.12B 457.15M 2026-03
West Pharmaceutical Services USD 2.99B 2.35B 2026-03